American Healthcare REIT (NYSE:AHR) Posts Quarterly Earnings Results, Misses Expectations By $0.35 EPS

American Healthcare REIT (NYSE:AHRGet Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.35), Zacks reports. American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.96%. The company had revenue of $523.81 million during the quarter, compared to the consensus estimate of $474.26 million. The business’s revenue for the quarter was up 12.8% compared to the same quarter last year. American Healthcare REIT updated its FY24 guidance to $1.40-1.43 EPS and its FY 2024 guidance to 1.400-1.430 EPS.

American Healthcare REIT Price Performance

American Healthcare REIT stock traded down $0.39 during trading hours on Thursday, reaching $26.41. 707,573 shares of the stock were exchanged, compared to its average volume of 1,450,831. The stock has a 50 day moving average of $25.16 and a two-hundred day moving average of $19.21. The company has a market cap of $3.48 billion and a P/E ratio of -55.84. The company has a current ratio of 0.29, a quick ratio of 0.29 and a debt-to-equity ratio of 0.60. American Healthcare REIT has a twelve month low of $12.63 and a twelve month high of $27.77.

American Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, September 20th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 3.79%. The ex-dividend date was Friday, September 20th. American Healthcare REIT’s dividend payout ratio (DPR) is presently -208.33%.

Analyst Ratings Changes

Several equities analysts recently weighed in on AHR shares. JMP Securities raised their target price on shares of American Healthcare REIT from $18.00 to $30.00 and gave the company a “market outperform” rating in a research note on Friday, September 20th. Bank of America upped their target price on shares of American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a report on Tuesday, September 24th. Morgan Stanley lifted their price target on American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a report on Thursday, August 22nd. KeyCorp upped their price objective on American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a research note on Monday, September 16th. Finally, Truist Financial lifted their target price on American Healthcare REIT from $22.00 to $27.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.00.

Read Our Latest Analysis on AHR

About American Healthcare REIT

(Get Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Featured Stories

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.